CW
IDXX icon

Connectus Wealth’s Idexx Laboratories IDXX Stock Holding History

Connectus Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$6.79M Sell
12,576
-202
-2% -$110K 0.19% 107
2023
Q4 		$7.09M Buy
12,778
+7
+0.1% +$3.29K 0.15% 140
2023
Q3 		$5.58M Sell
12,771
-1,785
-12% -$890K 0.12% 150
2023
Q2 		$7.31M Sell
14,556
-3,698
-20% -$1.77M 0.17% 118
2023
Q1 		$9.13M Sell
18,254
-5,999
-25% -$2.87M 0.22% 101
2022
Q4 		$9.89M Buy
24,253
+190
+0.8% +$73.8K 0.23% 101
2022
Q3 		$7.84M Sell
24,063
-21,415
-47% -$7.87M 0.16% 139
2022
Q2 		$16M Buy
45,478
+42,437
+1,395% +$17.3M 0.36% 86
2022
Q1 		$2M Sell
3,041
-826
-21% -$434K 0.06% 168
2021
Q4 		$2.55M Buy
+3,867
New +$2.43M 0.1% 121

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connectus Wealth's IDXX Position: Q1 2024 in Review

Connectus Wealth reduced its Idexx Laboratories (IDXX) stake by 1.6% in Q1 2024, selling an estimated $110K and leaving 12,576 shares worth $6.79M. The position accounts for 0.19% of the portfolio, ranked #107.

Connectus Wealth first reported a position in IDXX in Q4 2021 and has held it in 10 quarters since. The position peaked at $16M in Q2 2022. 1,148 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • Connectus Wealth held 12,576 shares of Idexx Laboratories worth $6.79M as of Q1 2024.
  • Connectus Wealth sold 202 Idexx Laboratories shares in Q1 2024, an estimated $110K.
  • Idexx Laboratories made up 0.19% of Connectus Wealth's portfolio in Q1 2024, its #107 holding.
  • Connectus Wealth first reported a position in Idexx Laboratories in Q4 2021 and has held it in 10 quarters since.
  • Connectus Wealth's Idexx Laboratories position peaked at $16M in Q2 2022.
  • 1,148 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.